Alvotech
ALVO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001898416
No open-market purchases or sales by Alvotech insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $157.4M in total; Oaktree Capital is the only superinvestor holding it.
Other share classesALVOW
13F holders, Q3 2024
Institutional positions in Alvotech as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- +1 vs. Q2 2024
- Shares held
- 15.2M
- +669.4K (+4.6%) vs. Q2 2024
- Total value
- $178.2M
- +$4.26M (+2.5%) vs. Q2 2024
- New holders
- 5
- 8 more added
- Sold out
- 4
- 10 more reduced
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALVO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 72 | $157.4M |
| Q1 2026 | 57 | $57.3M |
| Q4 2025 | 49 | $78.1M |
| Q3 2025 | 66 | $127.9M |
| Q2 2025 | 53 | $156.0M |
| Q1 2025 | 51 | $159.2M |
| Q4 2024 | 45 | $199.6M |
| Q3 2024 | 32 | $178.2M |
| Q2 2024 | 31 | $174.0M |
| Q1 2024 | 22 | $172.4M |
| Q4 2023 | 18 | $196.8M |
| Q3 2023 | 19 | $159.7M |
| Q2 2023 | 17 | $133.5M |
| Q1 2023 | 17 | $244.6M |
| Q4 2022 | 11 | $184.7M |
| Q3 2022 | 14 | $140.6M |
| Q2 2022 | 17 | $157.8M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Alvotech; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 3,173,124 | $37.9M | 0.00% | +13,375+0.4% | Added |
| Bracebridge Capital, LLC | 2,705,304 | $32.2M | 12.25% | 00.0% | Unchanged |
| Oaktree Capital Management LPSuperinvestorOaktree Capital | 2,532,027 | $30.1M | 0.50% | 00.0% | Unchanged |
| Morgan Stanley | 1,739,340 | $20.7M | 0.00% | +1,681,049+2,883.9% | Added |
| Littlejohn & Co LLC | 1,318,534 | $15.7M | 7.98% | 00.0% | Unchanged |
| Sculptor Capital LP | 945,098 | $11.1M | 0.22% | 00.0% | Unchanged |
| PointState Capital LP | 756,553 | $9.00M | 0.25% | +26,481+3.6% | Added |
| Legal & General Group Plc | 539,595 | $6.41M | 0.00% | −4,270−0.8% | Reduced |
| Geode Capital Management, LLC | 209,257 | $2.49M | 0.00% | +21,022+11.2% | Added |
| Farallon Capital Management, L.L.C. | 199,675 | $2.38M | 0.01% | +199,675 | New |
| Royce & Associates LP | 131,000 | $1.56M | 0.01% | +37,000+39.4% | Added |
| Millennium Management LLC | 126,475 | $1.51M | 0.00% | +10,457+9.0% | Added |
| Oaktree Fund Advisors, LLC | 118,744 | $1.41M | 1.59% | 00.0% | Unchanged |
| Northern Trust Corp | 109,849 | $1.31M | 0.00% | −265−0.2% | Reduced |
| Exome Asset Management LLC | 90,100 | $1.07M | 0.72% | −8,900−9.0% | Reduced |
| National Asset Management, Inc. | 50,000 | $605.0K | 0.02% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 34,111 | $406.0K | 0.00% | +34,111 | New |
| Marshall Wace, LLP | 33,213 | $395.2K | 0.00% | −5,779−14.8% | Reduced |
| TBH Global Asset Management, LLC | 30,500 | $362.9K | 0.08% | −3,000−9.0% | Reduced |
| Mariner, LLC | 25,107 | $298.8K | 0.00% | −1,113−4.2% | Reduced |
| Citadel Advisors LLC | 21,249 | $252.9K | 0.00% | +21,249 | New |
| Lodbrok Capital LLP | 181,587 | $237.9K | 0.19% | −534,227−74.6% | Reduced |
| Richmond Brothers, Inc. | 13,966 | $166.2K | 0.10% | 00.0% | Unchanged |
| Bank of America Corp | 13,563 | $161.4K | 0.00% | −6,656−32.9% | Reduced |
| Amundi | 11,357 | $145.9K | 0.00% | +4,657+69.5% | Added |
| Cubist Systematic Strategies, LLC | 11,273 | $134.1K | 0.00% | −2,004−15.1% | Reduced |
| FreeGulliver LLC | 43,681 | $118.4K | 0.07% | +43,681 | New |
| Wolverine Asset Management LLC | 5,841 | $69.5K | 0.00% | +5,841 | New |
| JPMorgan Chase & Co | 1,709 | $20.3K | 0.00% | −2,659−60.9% | Reduced |
| UBS Group AG | 968 | $11.5K | 0.00% | +966+48,300.0% | Added |
| Advisor Group Holdings, Inc. | 150 | $1.78K | 0.00% | 00.0% | Unchanged |
| Larson Financial Group LLC | 30 | $357 | 0.00% | 00.0% | Unchanged |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −848,444−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −11,656−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −1,184−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −9−100.0% | Sold out |